Sirona Biochem's accounts payable is $810K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Sirona Biochem (SRBCF) currently reports a accounts payable of $810K as of July 2024. That compares with $450K in the prior-year period — up 77.6% year over year. Use the charts on this page to explore Sirona Biochem's accounts payable history and peer comparisons.
Sirona Biochem's accounts payable increased from $450K to $810K — a 77.6% year-over-year increase (period ending July 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Sirona Biochem reported $810K in accounts payable as of July 2024. That compares with $450K in the prior-year period — up 77.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current accounts payable of $810K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Sirona Biochem, and consider following SRBCF for alerts when major investors trade the stock.
Sirona Biochem is classified in the Healthcare sector. On accounts payable, it currently shows $810K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SRBCF with unrelated industries.